Q: Why add cagrilintide to a GLP1/GIP/glucagon approach
Para continuar, ingresa atu cuenta trace-id: 8fce84f9-b20b-4ad5-8697-65f878f6f9b0 Usamos cookies para mejorar tu experiencia en Mercado Libre
Heart Failure Patients: Data suggest that discontinuing SGLT2 inhibitors in patients treated for heart failure may be associated with worsening heart failure, so maintaining treatment may be beneficial
Limited human evidence: Some human studies exist but are small or inconsistent
Patients were excluded if they had any other chronic liver disease other than MASLD/MASH including alcohol, viral, drug-induced, autoimmune, Budd-Chiari syndrome, Wilsons disease, alpha-1-antitrypsin deficiency, hereditary hemochromatosis, primary/secondary biliary cholangitis, primary sclerosing cholangitis, liver disorders in diseases classified elsewhere, and other chronic hepatitis not classified elsewhere
Request a free consultation with Dr